Tolvaptan

Ended Awarded

Contract number
36C24120N0812
Awardee
Awarding agency
Obligated
$30,104

Award facts

Contract value 100% obligated
$30,103.89 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Augusta, ME 04330, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Otsuka America Pharmaceutical Inc. was awarded a firm fixed price blanket purchase agreement call against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract has a potential value of $30,103.89 to deliver tolvaptan, a drug used to treat hyponatremia, with performance required by September 30, 2020 in Chelsea, Maine. No set-aside designation was applied to this award made under Master GSA Schedule FSS-61-IB to support the VA's healthcare programs.

Quick answers

Who was awarded contract 36C24120N0812?

36C24120N0812 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on July 21, 2020.

How much is contract 36C24120N0812 worth?

The government has obligated $30,104 on 36C24120N0812.

Is contract 36C24120N0812 an order under another contract?

Yes. 36C24120N0812 is a BPA call under 36F79720D0099-36E79720A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24120N0812 competed?

The extent of competition for 36C24120N0812 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login